Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimethoprim with ADT in Prostate Cancer
NCT06536374Phase 2Not yet recruiting
- Sponsor
- University of California, San Diego
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trimethoprim in prostate cancer (PCa), sponsored by University of California, San Diego. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
trimethoprim
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06536374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06536374.